Ozempic: What the Pharmaceutical Industry Doesn’t Want You to Know
And what the pharmaceutical industry doesn’t want you to know
A medication was recently approved by the FDA for diabetes management that also causes effortless weight loss. This has led to a surge in demand, even causing shortages for diabetic patients.
We’re talking about Ozempic (Semaglutide) and similar drugs (Ariana M. Chao et al., 2023).
We are currently facing a global pandemic of obesity and overweight, along with all the inflammatory side effects they bring—effects that seem to be increasing steadily.
According to the WHO (2024), 1 in every 8 people worldwide is living with obesity.
What is Ozempic and what is it used for?
Ozempic works by mimicking the action of the GLP-1 peptide, a hormone released after eating that promotes the release of insulin. It belongs to a group of hormones called incretins, which help regulate blood sugar levels and also act on the central nervous system, controlling appetite and satiety centers.
This results in reduced hunger, which leads to eating less—and that’s why you lose weight.
How many kilos can you lose with Ozempic?
Statistics show that on average, individuals lose around 15% of their initial body weight in treatments lasting up to 68 weeks (Ariana M. Chao et al., 2023).
For example, if you weigh 80 kg, you could lose 12 kg, bringing you down to 68 kg.
If your insurance doesn’t cover the medication…
Each kilogram you lose with Ozempic could cost you $500 USD!
We know you want to lose weight, that you’ve tried many times, that you’re stuck in that constant up and down…
You’re looking for more tools and you believe this medication might be the solution.
But there is no magic pill.
This medication is just a wild card.
If you’re considering Ozempic or are already using it…
We want to share its side effects—and how to counter them.
1. Delayed gastric emptying
This leads to poor digestion and nutrient absorption, affecting supplements and even other medications.
What you can do:
- Eat friendly foods that are easy for your gut to digest and don’t cause inflammation.
- That’s why we recommend removing grains, cow’s dairy, and sugars.
- Personalize your 3R Protocol for optimal support.
2. Nausea, gas, and abdominal discomfort
What you can do:
- Support your digestion with warm herbal infusions or a bit of warm water with lemon.
- Even better: use digestive enzymes to ease symptoms.
3. Loss of muscle mass (often due to reduced protein intake)
What you can do:
- Prioritize protein in every meal, according to your individual tolerance.
- Incorporate strength training into your routine.
- Evaluate your body composition regularly to make sure the weight you’re losing is fat—not muscle.
Discover the root cause of your inflammation and change your habits—at NutriWhite, we can help!
You can achieve a lasting alternative for weight loss—without rebound—through immunonutrition!
In your NutriWhite Consultation, we support you in your journey toward healthier habits that promote gut health through personalized immunonutrition.
Learn more about our consultation plans by clicking here.
REFERENCES
- Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023 Apr;33(3):159–166.
https://pubmed.ncbi.nlm.nih.gov/34942372/ - Christoffersen BØ, Sanchez-Delgado G, John LM, Ryan DH, Raun K, Ravussin E. Beyond appetite regulation: Targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss. Obesity (Silver Spring). 2022 Apr;30(4):841–857.
- Hira T, Trakooncharoenvit A, Taguchi H, Hara H. Improvement of Glucose Tolerance by Food Factors Having Glucagon-Like Peptide-1 Releasing Activity, 2021.
- Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. Risk of Gastrointestinal Adverse Events Associated With GLP-1 Receptor Agonists for Weight Loss. JAMA. 2023 Nov 14;330(18):1795–1797.
- Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q. Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Front Public Health. 2022 Oct 20;10:996179.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631444/ - Fragozo-Ramos MC. Metabolic syndrome: a literature review, 2022.
https://docs.bvsalud.org/biblioref/2022/06/1370951/sindrome-metabolico.pdf - León-Pedroza JI, González-Tapia LA, del Olmo-Gil E, Castellanos-Rodríguez D, Escobedo G, González-Chávez A. Low-grade systemic inflammation and its link to metabolic disease: from molecular evidence to clinical application
.png)
